Our results support their findings that the androgen receptor has a critical role in regulating expression of genes involved in prostate cancer and the GWAS risk markers and their correlated variants may be located in enhancer regions and function to regulate the expression of a subset of these target genes. The gene discussed is AR; the disease is prostate cancer.